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ABSTRACT
The overall aim of this study was to compare differ-
ent intervention strategies for clinical intramammary 
infections (IMI). We conducted a simulation study to 
represent a Danish dairy cattle herd with IMI caused 
mostly by Staphylococcus aureus and 9 different inter-
vention strategies for clinical IMI. A standard interven-
tion of 3 d of treatment consisting of intramammary 
injections for all clinical cases was used. Two of the 
strategies reflected the use of more antibiotics and 6 
strategies reflected cow-specific treatment or culling 
decisions. For these strategies, we assessed the cost 
and effectiveness of culling as an IMI intervention. Our 
results showed that nearly all strategies could reduce 
the number of IMI cases [e.g., a median of 37 clinical 
cases with the extended intramammary treatment over 
5 d strategy (Basic5) and 30 clinical cases with the cow 
culled with recovery probability below 50% (Before50)] 
compared with the standard intervention (median of 42 
clinical cases). This happened alongside either increased 
antibiotic usage (e.g., from a median of 123 treatment 
days up to 179 treatment days with strategy Basic5) or 
an increased number of cows culled in relation to IMI 
(e.g., from a median of 16 up to 24 cows with strategy 
Before50). Strategies with more antibiotics or reactive 
culling had a slightly higher net income (e.g., €190,014 
median net income with strategy Basic5 or €196,995 
with strategy Before50 compared with €187,666 with 
the standard strategy). This shows that a cow-specific 
clinical intervention approach can be cost-effective in 
reducing IMI incidence.
Key words: treatment, culling, cow-specific, simulation 
model
INTRODUCTION
Mastitis, or IMI, is frequently found on dairy farms. 
It causes considerable economic losses (Halasa et al., 
2007), impairs animal welfare (Broom, 1991; von Key-
serlingk et al., 2009), and is one of the main reasons 
for the use of antibiotics in dairy cattle in Denmark 
(DANMAP, 2016; EMA and EFSA, 2017).
Costs related to clinical IMI can be divided into 
those associated with treatment, costs from increased 
mortality through culling (i.e., replacement of culled 
animals), and indirect costs from production losses 
(Halasa et al., 2007), all of which have previously been 
investigated in several studies (e.g., Bar et al., 2008). 
Those studies relied on a modeling approach in which 
a farm with IMI was simulated and the resulting costs 
were calculated. Some previous studies focused on 
modeling the occurrence or transmission of IMI-causing 
pathogens (Allore et al., 1998; Østergaard et al., 2005; 
Hagnestam-Nielsen and Østergaard, 2009; Halasa et 
al., 2009a), whereas others investigated intervention 
(Steeneveld et al., 2011; Halasa, 2012) or replacement 
strategies (Cha et al., 2014). Many of those studies also 
took into account the IMI-causing pathogen, and are 
thus pathogen-specific (Allore et al., 1998; Østergaard 
et al., 2005; Halasa et al., 2009a), as the effects of an 
IMI (e.g., milk production losses) may depend on the 
causative pathogen (Gröhn et al., 2004; Hertl et al., 
2014).
Intervention strategies investigated for clinical cases 
usually consist of (mainly intramammary) antibiotic 
treatment. However, in the light of rising consumer 
awareness regarding antibiotic usage in food animals 
and its connection with antimicrobial resistance (Ruegg, 
2003), it may be prudent to search for alternative in-
tervention strategies. For instance, culling cows with 
clinical mastitis could be a valid alternative. In contrast 
to antibiotic treatment, however, culling of infected ani-
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mals is rarely considered as an intervention strategy for 
IMI, but rather as a possible consequence (Halasa and 
Hogeveen, 2018). Culling was studied in the context of 
optimal replacement decisions (Heikkilä et al., 2012; 
Cha et al., 2014), where it led to only a slightly earlier 
optimal replacement time for cows with clinical IMI; 
therefore, treatment was recommended over culling 
in most cases. Previous studies evaluated the optimal 
replacement time in economic terms, comparing results 
for cows with and without IMI; however, to the best 
of our knowledge, specific culling strategies for clinical 
IMI have not yet been the focus of any study.
In addition to antibiotic treatment or culling of cows 
with clinical mastitis, it may also be economically ben-
eficial to reduce the transmission of IMI-causing patho-
gens; for instance, by improving hygiene or biosecurity. 
However, if pathogen transmission is contagious, the 
number of new cases depends on the number of infected 
animals (Halasa et al., 2009a). Reducing the transmis-
sion of IMI-causing pathogens may therefore lead to a 
long-term indirect cost reduction due to a decreased 
number of new cases (Steeneveld et al., 2011). Conse-
quently, the long-term effects of reducing transmission 
must be evaluated with a model that includes transmis-
sion dynamics, as in the study by Halasa (2012).
The aim of the current study was to evaluate differ-
ent IMI intervention strategies for clinical contagious 
mastitis using 2 distinct approaches (more antibiotics 
and reactive culling). For this purpose, cow- and patho-
gen-specific IMI transmission were modeled for a Dan-
ish dairy cattle herd with 200 dairy cows. Strategies, 
including cow-specific antibiotic treatment of clinical 
cases and culling of individual cows with clinical IMI, 
were compared for farm economic and epidemiological 
parameters, including the number of clinical IMI cases, 
culled cows, and antibiotic doses (treatment days).
MATERIALS AND METHODS
Herd and Transmission Model
Herd Model. The model we used was the MiCull 
(Mastitis-iCull) model, version 2.0. The original MiCull 
model, version 1.0 (Gussmann et al., 2018b), was used 
in Kirkeby et al. (2017) and differs only in the possible 
interventions for clinical IMI, which are new in version 
2.0, as explained below. The model and all simulations 
were programmed and run in the statistical computing 
software R version 3.2.2 “Fire Safety” (R Core Team, 
2015). Figures were created using the package ggplot2 
(Wickham, 2009).
In the model, a dairy herd with 200 cows was simu-
lated in single-day time steps (Kirkeby et al., 2016). 
The cows were distributed over 5 compartments (calves, 
heifers, lactating cows, dry cows, and calving cows). 
After a stochastically determined number of days, each 
cow moved on to the next compartment unless culled. 
Feeding depended on the compartment, and, for lactat-
ing cows, the produced milk was taken into account. 
Lactation (milk, protein, and fat) and SCC curves were 
cow-specific (Græsbøll et al., 2016) and adjusted for 
IMI effects, such as increased SCC (Schepers et al., 
1997; Wilson et al., 1997) and decreased milk yield 
(Hortet et al., 1999; Gröhn et al., 2004). Milk from 
clinically affected cows was discarded during antibiotic 
treatment and for the following 6 d. The milk yield 
and SCC were recorded once per month. The future 
average milk production (FAP) of a cow was estimated 
(Græsbøll et al., 2017). Model parameters can be found 
in Table 1.
Transmission Framework. The model included 5 
pathogen strains that can cause IMI: contagious Staph-
ylococcus aureus, environmental Escherichia coli, both 
contagious and an environmental Streptococcus uberis, 
and Streptococcus agalactiae with both contagious and 
environmental elements combined. Other pathogens 
were not included due to missing parameters. Trans-
mission parameters are shown in Table 1 and Supple-
mental Table S1 (https: / / doi .org/ 10 .3168/ jds .2018 
-14939). Median daily number of heifers and cows per 
strategy is shown in Supplemental Table S2 (https: / / 
doi .org/ 10 .3168/ jds .2018 -14939). The IMI transmission 
module was adapted and extended from Halasa et al. 
(2009a, 2010). Heifers were modeled separately from 
the lactating herd until they calved, at which point 
they had a certain probability of entering their first 
lactation in an infected state. For new infections in 
lactating cows, the infection probability was calculated 
for every noninfected quarter; this probability was de-
termined by the active pathogen strains, the number of 
infected quarters for contagious strains, and the suscep-
tibility of the cow. The susceptibility of a cow takes into 
account risk factors, such as parity and previous IMI 
(Zadoks et al., 2001), and adjusts susceptibility relative 
to previously uninfected primiparous cows. There is a 
pathogen-specific probability for every new infection 
to immediately appear as a clinical case, otherwise it 
will be subclinical (Halasa et al., 2009a). Furthermore, 
previously infected quarters have a certain pathogen-
specific probability for spontaneous recovery from the 
subclinical state or to flare up from subclinical to clini-
cal. Clinical quarters are treated with a 3-d antibiotic 
intramammary injection, after which the clinical quar-
ter will return to either susceptible or subclinical status 
(see Table 2), depending on the recovery probability of 
the individual cow (Steeneveld et al., 2011).
If a cow had a clinical IMI during lactation or a high 
SCC (200,000 or higher) at 1 of the last 3 monthly 
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recordings, a pooled milk sample was sent for testing by 
PCR (sensitivity and specificity are given in Table 2) 
before drying off. Cows with a positive PCR test result 
received antibiotic dry cow treatment, whereas cows 
with a negative result were dried off without dry cow 
treatment. New infections can occur during the first 
and last week of the dry period, but infection probabil-
ity does not depend on the number of infected quarters 
and is lower for cows that received dry cow treatment 
(Halasa et al., 2009b). Similarly, subclinical cases can 
only flare up to become clinical cases in the first and 
last week of the dry period for cows without dry cow 
treatment. Cows that become clinical cases in the first 
week will also receive dry cow treatment. Spontaneous 
recovery can occur throughout the entire dry period 
(Halasa et al., 2010).
Culling. Cows were evaluated for culling once a 
week if the number of lactating and dry cows exceeded 
the target count of 200 dairy animals (Kirkeby et al., 
2016). All cows received weighted flags for low milk 
yield, parity, reproduction status, high SCC, and previ-
ous cases of clinical IMI, and those with the highest 
weightings were culled. There was also a certain prob-
ability that some cows would have to be culled for other 
reasons, such as lameness (Kirkeby et al., 2016). This 
involuntary culling took precedence over voluntary cull-
ing. The cost of culling was around €1,000 per cow (i.e., 
the price of a new heifer), not including the income 
from slaughter. However, the mean slaughter value was 
deducted for every culled cow, resulting in a cost of less 
than €1,000 each.
Intervention Strategies for Clinical IMI
We simulated a Danish dairy cattle herd with a 
default yearly median cumulative clinical incidence of 
about 21% at cow level, mostly caused by Staph. aureus.
Default Treatment for All Cows. The default in-
tervention in the model for clinical IMI was intramam-
mary treatment over 3 d (Basic3). The second strategy 
Table 1. Prices used in the model to calculate income (positive values) and costs (negative values)
Item
Price  
(€)  Reference
1 kg of protein 5.8132 www .arla .dk, September 2017
1 kg of fat 4.1519 www .arla .dk, September 2017
Handling of 1 kg of milk −0.01343 www .arla .dk, September 2017
Slaughter value per cow 483 Kudahl et al. (2007)
Feeding   
 Per calf per day −0.0026 Kirkeby et al. (2016)
 Per heifer/dry cow per day −0.9311 Kirkeby et al. (2016)
 Per ECM −0.1947 Kirkeby et al. (2016)
Treatment (per day) −11.10 Michael Farre (SEGES, Aarhus, Denmark, personal communication)
Opportunity cost (per case per day) −6.66 Halasa et al. (2009a); Michael Farre (SEGES, Aarhus, Denmark, personal 
communication)
Dry cow treatment −9.60 Michael Farre (SEGES, Aarhus, Denmark, personal communication)
Bacterial culture −12 Michael Farre (SEGES, Aarhus, Denmark, personal communication)
PCR −13.3 Michael Farre (SEGES, Aarhus, Denmark, personal communication)
Table 2. Model parameters for the main causative pathogen Staphylococcus aureus during lactation
Parameter  Description Value  Reference
Transmission rate Daily rate for susceptible quarters entering infected 
state
0.0009 Fitted value
Probability of clinical state Probability of a quarter entering clinical state upon 
infection
0.17 Supplemental Table S11
Flare up probability Daily probability of a subclinical quarter becoming 
clinical
0.0081 Supplemental Table S1
Spontaneous recovery probability Daily probability of a subclinical quarter becoming 
susceptible (without treatment)
0.0064 Supplemental Table S1
Recovery probability Probability of a clinical quarter becoming susceptible 
after treatment
0.4 Supplemental Table S1
Test sensitivity Test sensitivity for bacterial culture 0.523 Mahmmod et al. (2013)
 Test sensitivity for PCR (used at drying off) 0.908 Mahmmod et al. (2013)
Test specificity Test specificity for bacterial culture 0.895 Mahmmod et al. (2013)
 Test specificity for PCR (used at drying off) 0.988 Mahmmod et al. (2013)
Probability of identifying pathogen Probability of identifying causative pathogen by PCR 0.85 Taponen et al. (2009)
1https://doi .org/ 10 .3168/ jds .2018 -14939.
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consisted of an extended intramammary treatment over 
5 d (Basic5). In the following strategies, treatment was 
always 3 d of intramammary treatment, unless speci-
fied otherwise.
Longer Treatment for High-Producing Cows. 
As described above, the FAP was used to determine 
cows in the top 25% of expected future milk produc-
tion. In this strategy (Longer), cows were treated for 5 
instead of the usual 3 d.
Culling of Repeated Clinical IMI Cases. In this 
strategy, cows with clinical IMI for the second time in 
their current lactation (Repeated) were culled instead 
of treated.
Testing Before Treatment. In these strategies, 
clinical cases were not immediately treated. Instead, 
a milk sample of the new clinically affected quarter 
was sent for testing by PCR with 85% probability of 
identifying the causative pathogen, as described by Ta-
ponen et al. (2009). Test results were returned after 1 
d and were used to calculate the expected probability 
of recovery based on the causative pathogen, history of 
IMI, parity, DIM, and SCC at the last monthly milk 
recording (Steeneveld et al., 2011). If the pathogen 
could not be identified, a mean base cure probability 
representing an average pathogen was used instead of 
the cure probability for the actual causative pathogen. 
The estimated recovery probability was used to decide 
whether a cow should be culled [recovery probability 
below 50% (Before50) or 75% (Before75)] or treated.
Culling with Exceptions. With the Before75 strat-
egy, the farmer may also decide not to cull a certain 
group of cows; for example, cows in the top 25% ac-
cording to the FAP (notCullTop) or cows that are more 
than approximately 4 mo pregnant (notCullPregnant). 
These cows were always treated without sending a milk 
sample for testing.
Testing After Treatment. In a similar way to the 
testing before treatment strategy, quarters were tested 
by bacterial culture 7 d after treatment ended (After). 
Test sensitivity and specificity were 0.523 and 0.895, 
respectively (Mahmmod et al., 2013). If the test result 
was positive when it returned 1 d later, the cow would 
be culled.
Simulations and Model Output
For each of the 9 strategies described, we ran 500 
iterations for a period of 5 yr with an additional 5-yr 
burn-in time to ensure stable results (see Gussmann et 
al., 2018b), which described the effect of the strategies 
rather than the initial parameter values (transmission 
parameters are given in Table 2).
Model output was collected in the simulated 5-yr 
period and included economic factors such as income 
from milk (calculated from the fat and protein price, 
a milk handling fee, and a penalty or bonus depending 
on the bulk tank SCC), costs related to IMI (testing, 
treatment including opportunity costs, culling, dry 
cow treatment), and other costs (culling with a high 
SCC or history of IMI, feed). Prices are given in Table 
1. These costs were subtracted from the income from 
milk to calculate a mean (over 5 yr) yearly income for 
the farm, from which additional expenses (e.g., costs 
related to other diseases or running costs) had not yet 
been deducted. The output also included epidemio-
logical parameters, such as the number of clinical cases 
(quarters entering a clinical state from a susceptible 
or subclinical state), the number of subclinical cases 
(quarters entering a subclinical state from a susceptible 
or clinical state), the number of culled cows (due to IMI 
intervention, or with a high SCC or history of IMI), 
and the number of treatment days (e.g., 3-d treatment 
of a clinical quarter equals 3 treatment days) over the 
simulated 5-yr period. The numbers were rounded to 
integers or, in the case of percentages, to one decimal 
place.
Sensitivity Analyses
Sensitivity analyses were performed for different 
parameters (Table 3). These included (1) diagnostic 
test characteristics [the probability of identifying the 
pathogen according to Taponen et al. (2009), or the test 
sensitivity and specificity according to Cederlöf et al. 
(2012)]; (2) the base cure probability after treatment; 
(3) the fat and protein prices for 2017 in Denmark 
(www .arla .dk/ om -arla/ ejere/ arlapris/ 2017); (4) prices 
for culling; and (5) transmission rates and causative 
pathogens (reflecting different herds).
RESULTS
All results for the strategies we used can be found in 
Table 4. The numbers presented are rounded median 
values (with the 5th and 95th percentiles) of the an-
nual average over the 5 simulated years. Clinical and 
subclinical cases are always at quarter level.
In the basic strategy (Basic3), we observed 42 clinical 
cases (median) per year, ranging from 33 to 51 cases 
for the 5th and 95th percentiles, respectively (Table 4). 
These cases led to a median 123 treatment days per 
year. We noted another 136 subclinical cases (median), 
and 16 cows with a high SCC or a history of IMI were 
culled (median). The median yearly income in the Ba-
sic3 strategy was €187,666 (Table 4).
Comparable numbers for clinical cases and culled 
cows could be observed when the high-producing cows 
were treated for 5 d instead of 3 (Longer), but with 
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a higher median and variance in treatment days. The 
median number of subclinical cases was lower, with a 
higher variance skewed to the left (Table 4). If all cows 
were treated for 5 d (Basic5), the median number of 
clinical cases and of subclinical cases was lower and 
the median number of treatment days increased. The 
number of culled cows was slightly lower (Table 4). The 
median yearly income remained similar across these 
strategies (Table 4).
For the Repeated strategy, in which cows with multi-
ple clinical IMI cases were culled, the number of clinical 
cases resembled the number of clinical cases in Basic5, 
but with fewer treatment days and more culled cows, 
including cows culled in relation to IMI intervention 
(Table 4). In all other strategies that included reactive 
culling, we found fewer clinical cases, with the small-
est median of 29 cases in the Before75 strategy. The 
numbers of subclinical cases in the Repeated and After 
strategies were higher than in Basic5, but lower than in 
Basic3 and Longer. All other strategies that included 
culling showed fewer subclinical cases, with the small-
est median of 106 in the Before75 strategy. All culling 
strategies had a larger number of culled cows than the 
strategies without culling as an intervention, up to a me-
dian of 32 cows culled per year in the Before75 strategy. 
In addition, the median number of treatment days was 
lower, with a minimum of 7 treatment days (median) 
in the Before75 strategy. In general, a higher number of 
treatment days corresponded to fewer culled cows; an 
exception was the strategy After, which resulted in more 
treatment days and more culled cows than the strategy 
Repeated (Table 4). The median yearly income in the 
Repeated and After strategies was around €191,500. 
In the strategies Before50, Before75, notCullPregnant, 
and notCullTop, yearly income varied from €195,600 
(notCullPregnant) to €197,576 (Before75).
Table 3. Values used in the sensitivity analyses [default values (Tables 1 and 2) are marked by an asterisk]
Sensitivity analysis Values
Test characteristics      
 Sensitivity/specificity of bacterial culture 0.52/0.9* 0.78/0.97 0.83/0.97 0.88/0.94 0.94/0.9
 Probability of identifying a pathogen by PCR 0.9 0.85* 0.8 0.75 0.5
Base cure probability 0.2 0.4* 0.6 0.7  
Milk price      
 1 kg of protein/1 kg of fat (€) 5.25/3.75 5.51/3.94 5.66/4.04 5.81/4.15* 5.92/4.23
Additional costs for culling (€) 0* 250 500 1,000  
Transmission rates per quarter per day      
 Low-incidence herd      
  Staphylococcus aureus 0.00004     
  Streptococcus uberis (contagious) 0.0002*    
  Strep. uberis (environmental) 0.000002*    
 High-incidence herd (Staph. aureus) 0.0018     
 Medium-incidence herd (contagious Strep. uberis) 0.0047     
 Medium-incidence herd (environmental Strep. uberis) 0.00009     
Table 4. Median model output (with 5th and 95th percentiles) of 500 iterations for a herd with 200 dairy cows, simulated over 5 yr: net income 
(in €, income from milk minus costs related to IMI and feeding), number of clinical IMI cases, number of subclinical IMI cases, number of 
treatment days, and number of culled cows (due to IMI intervention, or with a high SCC or history of IMI)1
Strategy Net income (€)  
Clinical  
IMI cases  
Subclinical  
IMI cases  
Treatment  
days  
Culled  
cows
Basic3 187,666 (173,363; 202,147) 42 (33; 51) 136 (121; 161) 123 (95; 151) 16 (12; 20)
Basic5 190,014 (175,823; 205,741) 37 (19; 46) 123 (86; 145) 179 (93; 220) 15 (11; 18)
Longer 188,307 (175,953; 203,414) 41 (27; 51) 133 (109; 157) 129 (81; 162) 16 (12; 19)
Repeated 191,280 (179,588; 205,338) 38 (21; 46) 125 (90; 145) 86 (53; 106) 20 (14; 25)
After 191,699 (179,990; 207,164) 35 (15; 43) 129 (80; 147) 101 (46; 125) 22 (13; 27)
Before50 196,995 (181,427; 211,492) 30 (15; 38) 111 (75; 130) 47 (36; 64) 24 (10; 29)
Before75 197,576 (184,745; 213,907) 29 (13; 35) 106 (71; 120) 7 (4; 11) 32 (18; 38)
notCullTop 196,704 (182,197; 213,318) 32 (14; 39) 113 (72; 127) 32 (12; 43) 29 (16; 34)
notCullPregnant 195,600 (184,007; 210,633) 31 (14; 37) 112 (74; 123) 24 (12; 32) 30 (17; 35)
1All values refer to the annual means over 5 simulated years and numbers are rounded to whole euro. The simulated strategies were Basic3 (all 
clinical cases were treated for 3 d with antibiotics, default strategy), Basic5 (all clinical cases were treated for 5 d), Longer [high-producing cows 
(top 25%) were treated for 5 d instead of 3 d], Repeated (cows with repeated clinical cases were culled instead of being treated), After (cows 
were tested 7 d after treatment, still infected cows were culled), Before50 (cows were tested before treatment and cows with a cure probability 
below 50% were culled instead of treated), Before75 (similar to Before50, but cows with a cure probability below 75% were culled), notCullTop 
[similar to Before75, but high-producing cows (top 25%) were exempt from culling], notCullPregnant [similar to Before75, but pregnant cows 
(at least 4 mo) were exempt from culling].
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Sensitivity analysis (see Table 3 for input values) on 
test characteristics showed that varying the probability 
of identifying the pathogen by PCR before treatment 
did not lead to considerable changes in the results. The 
income did not change substantially when increasing 
sensitivity (thus decreasing specificity) for bacterial 
culture in the After strategy, whereas the number of 
clinical IMI cases and treatment days per year de-
creased (Supplemental Figure S1; https: / / doi .org/ 10 
.3168/ jds .2018 -14939).
An increased base cure probability after treatment 
led to increased income and a decreased number of clin-
ical IMI, treatment days, and culled cows in all strate-
gies, though the effect was less apparent in strategies 
where cows were tested and culled before treatment. 
In the Before50 strategy, the number of clinical IMI 
and treatment days increased with increasing base cure 
probability (Figure 1).
Sensitivity analysis for the fat and protein prices 
(Danish prices from 2017) showed that yearly income 
is highly dependent on the milk price, with medians 
ranging from €120,597 to €200,096 in the Basic3 strat-
egy. Other strategies showed a similar pattern in the 
relationship between milk price and yearly income 
(Supplemental Figure S2; https: / / doi .org/ 10 .3168/ jds 
.2018 -14939).
When culling was more expensive, the yearly income 
was lower. This effect was more pronounced in strate-
gies with a larger number of culled cows (Supplemental 
Figure S3; https: / / doi .org/ 10 .3168/ jds .2018 -14939). 
This led to greater discrepancies in yearly income 
among the different intervention strategies.
Figure 1. Results of the sensitivity analysis for the base cure rates in selected strategies (increasing cure rates from left to right, Table 3). 
Box plots show yearly income (income from milk minus costs for IMI intervention, dry cow treatment, feed, and culling) and yearly cumulative 
clinical IMI incidence for 500 iterations. Grey boxes show results with default values. The mean over the simulated 5-yr period was used for 
each iteration. The boxes show the lower and upper quartiles and the median (mid line). The whiskers show the lower and upper values in 1.5 
interquartile range of the lower and upper quartiles. The dots show outliers. The selected strategies are Basic3 (all clinical cases were treated for 
3 d with antibiotics, default strategy), Repeated (cows with repeated clinical cases were culled instead of being treated), Before50 (cows were 
tested before treatment and cows with a cure probability below 50% were culled instead of treated), and notCullTop [similar to Before50, but 
cows with a cure probability of less than 75% were culled, with high-producing cows (top 25%) being exempt from culling].
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Sensitivity analyses for transmission rates led to 
varying cumulative clinical incidences. When a herd 
with a default median cumulative clinical incidence of 
around 19% was modeled, and in which most cases were 
caused by an environmental Strep. uberis strain, results 
showed a similar trend, albeit less pronounced (Figure 
2). If most cases were caused by a contagious Strep. 
uberis strain, differences were more noticeable (Figure 
2); for example, the variation in the results was higher. 
Furthermore, in the strategies Before75 (results not 
shown), notCullPregnant, and notCullTop, the median 
number of clinical cases and culled cows were lower, 
but the range of results was comparable. Similar to 
the environmental strain, the contagious Strep. uberis 
strain led to a higher number of clinical cases and a 
lower median yearly income in the Before50 strategy. 
In the other strategies, the median yearly income was 
higher for both Strep. uberis strains.
Results for a herd with a lower (8%) median cumula-
tive clinical incidence can be seen in Figure 2. In a 
herd with a low number of clinical cases, the yearly 
income was higher and differences across the various 
intervention strategies were smaller. In contrast, in a 
herd with a higher (35%) median cumulative clinical 
incidence, in which most cases were caused by Staph. 
aureus, the income was lower and the differences among 
strategies were larger. For such a herd, the cumulative 
clinical incidence could be reduced to a median of 22% 
through the intervention strategy Before75 (results not 
shown), which also substantially reduced the number of 
Figure 2. Results of the sensitivity analysis for transmission rate (light gray; left is low transmission rate, right is high transmission rate of 
Staphylococcus aureus, Table 3) and main causative pathogens (white; left is contagious Streptococcus uberis, right is environmental Strep. uberis, 
Table 3). Box plots show yearly income (income from milk minus costs for IMI intervention, dry cow treatment, feed, and culling) and yearly 
cumulative clinical IMI incidence for 500 iterations. Dark gray boxes show results with default values (Table 2). The mean over the simulated 
5-yr period was used for each iteration. The boxes show the lower and upper quartiles and the median (mid line). The whiskers show the lower 
and upper values in the 1.5 interquartile range of the lower and upper quartiles. The dots show outliers. The presented strategies are Basic3 (all 
clinical cases were treated for 3 d with antibiotics, default strategy), Repeated (cows with repeated clinical cases were culled instead of being 
treated), Before50 (cows were tested before treatment and cows with a cure probability below 50% were culled instead of treated), notCullTop 
[similar to Before50, but cows with a cure probability of less than 75% were culled, with high-producing cows (top 25%) being exempt from 
culling], and notCullPregnant (similar to notCullTop, but pregnant cows instead of high-producing cows were exempt from culling).
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treatment days. However, 23% of the cows were culled 
for reasons related to IMI (results not shown).
DISCUSSION
The objective of our study was to evaluate different 
intervention strategies for clinical IMI. Nine strate-
gies were presented in the study. The default strategy 
(Basic3) included no reactive culling and all clinical 
cases were given intramammary treatment for 3 d. 
Two strategies reflected interventions with increased 
antibiotic use (Basic5, Longer). Six interventions ex-
plicitly included reactive culling as an intervention for 
IMI, where decisions to cull or treat cows with clinical 
IMI were made at the individual animal level: culling 
instead of treatment (Before50, Before75, notCullTop, 
notCullPregnant, and Repeated) or for cows that were 
not cured (After).
Although some previous studies have investigated 
IMI intervention and culling in relation to clinical 
IMI (Halasa, 2012; Heikkilä et al., 2012; Cha et al., 
2014), culling as a strategy, as presented in the current 
study, has rarely been considered as a reactive measure 
(Halasa and Hogeveen, 2018). Furthermore, in other 
IMI intervention studies, IMI transmission was seldom 
taken into account. In the present study, we modeled 
both IMI transmission and interventions, allowing for 
an evaluation of the long-term effects of the different 
strategies. Another novel aspect of the current study is 
that both economic and epidemiological consequences 
are presented as output. Farmers are not only inter-
ested in farm economics, but also in other perceived 
benefits (Valeeva et al., 2007; Jansen and Lam, 2012). 
Clinical IMI cases are perceived as both cost- and 
time-intensive (Jansen et al., 2009), and presenting the 
number of clinical cases alongside the economic impli-
cations could provide farmers with different incentives 
to adopt a new strategy. The number of treatment days 
and cows culled in relation to IMI are also shown to 
give an estimate of antibiotic use and longevity, which 
may affect the choice of an intervention strategy.
Our results showed that economically (based on year-
ly income), all strategies seemed more successful than 
the default 3-d intramammary treatment for all clinical 
cases (Basic3). Using more antibiotics (Basic5, Longer) 
led to only a small increase in yearly income (around 
€2,000 more median net income, Basic5), whereas the 
increase was higher in intervention strategies with reac-
tive culling (around €8,000 to €10,000 more median net 
income with strategies Before50, Before75, notCullTop, 
and notCullPregnant). Testing new clinically affected 
quarters and subsequent cow-specific treatment or 
culling decisions (Before50, Before75, notCullTop, and 
notCullPregnant) led to a higher income than testing 
a week after treatment (After) or culling cows with 
repeated cases (Repeated). These results are not con-
sistent with an earlier study that found cow-specific 
treatment was not economically beneficial (Steeneveld 
et al., 2011); however, that study did not model IMI 
transmission. By including transmission in our study, 
we were able to take into account the reduction in the 
number of IMI cases due to an intervention strategy 
and thus explain the higher yearly income, consistent 
with the findings of Halasa (2012).
Increasing the sensitivity of bacterial culture resulted 
in fewer cases (Supplemental Figure S1; https: / / doi .org/ 
10 .3168/ jds .2018 -14939). This is in accordance with the 
results of van den Borne et al. (2010), who showed that 
the sensitivity of the test to detect subclinical IMI had 
a substantial effect on the cost-effectiveness of control 
strategies. The results were also sensitive to the cure 
(Figure 1) and transmission rates (Figure 2), which is 
consistent with studies by Halasa (2012) and Down et 
al. (2013). Unfortunately, few studies have estimated 
the transmission rates of a small number of IMI-causing 
pathogens. Further studies with a focus on assessing 
the effect of control strategies on the transmission of 
IMI-causing pathogens are therefore required. This 
would allow a more precise assessment of the cost-
effectiveness of IMI control in dairy herds.
Sensitivity analysis for the cost of culling showed that 
income decreased with increasing culling costs (Supple-
mental Figure S3; https: / / doi .org/ 10 .3168/ jds .2018 
-14939); the opposite was true for increased milk prices 
(Supplemental Figure S2; https: / / doi .org/ 10 .3168/ jds 
.2018 -14939). Increased culling costs or reduced milk 
prices may therefore also have a substantial effect on 
the cost-effectiveness of an intervention strategy, and 
these factors should be taken into account when decid-
ing which intervention strategy to adopt, especially if 
reactive culling is considered. It is important to men-
tion that we had fixed prices over time. Although we 
acknowledge that this is unrealistic, it is not only dif-
ficult to predict changes in prices, but fixing a price 
also removes extra noise that would make it more chal-
lenging to compare different strategies.
Sensitivity analysis for the transmission rate of the 
main causative pathogen showed that adopting an in-
tervention strategy for clinical IMI was not in itself 
sufficient to reach a herd incidence that was sufficiently 
low and stable to be comparable to a scenario with 
low transmission due to good hygiene (see Figure 2). 
Very few studies have investigated the effect of hygiene 
measures. Lam et al. (1996) investigated the effect of 
postmilking teat disinfection and found that it reduced 
the transmission rate noticeably. Huijps et al. (2010) 
estimated the costs and effects of various individual 
hygiene measures, though not in terms of transmission 
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rates. Due to the lack of studies investigating the effect 
of a comprehensive hygiene strategy on the transmis-
sion rate of IMI pathogens within a herd, we did not 
include the costs arising from such a strategy to reduce 
transmission in the current study; this made it difficult 
to properly assess the cost-effectiveness of such a strat-
egy. Nevertheless, considerable profit was seen when 
reducing the transmission rate (Figure 2), though it 
remains to be seen whether the economic gain would 
be enough to improve herd hygiene enough to reach 
the assumed lower transmission rate. Even so, from an 
epidemiological point of view, improving hygiene led to 
better results than a higher use of antibiotics or more 
culling.
Our results showed 3 ways to improve the IMI situ-
ation (i.e., reduce the number of not only clinical but 
also subclinical quarter cases) within a herd compared 
with the default scenario of 3-d intramammary treat-
ment for all clinical quarters. The first was to increase 
the use of antimicrobials to treat clinical IMI cases 
(Basic5). Where this is not desirable, an alternative 
would be to cull reactively (After, Repeated, Before50, 
Before75, notCullTop, and notCullPregnant). In this 
case, antibiotic treatment could be greatly reduced but 
the number of cows culled in relation to IMI increased. 
Choosing between these 2 options could be seen as a 
decision between an increased risk of antimicrobial 
resistance (more antibiotics) or decreased longevity 
(more culling).
From an economic point of view, culling seemed to 
be the better choice in the studied herd with a medium 
cumulative clinical incidence. However, for a high cu-
mulative clinical incidence, the distinction was not as 
clear and depended on the individual culling strategies 
(Figure 2), whereas it was nearly indiscernible when 
the cumulative clinical incidence was low (Figure 2). 
Furthermore, the sensitivity analysis showed that the 
economic advantage of reactive culling could be negated 
by culling costs that exceeded a certain amount, and in 
this case costs caused by a high culling rate could not 
be counteracted by the increased income from milk.
The third option, reducing the transmission level in 
the herd through other means (e.g., hygiene or biosecu-
rity), was the only possible way to decrease IMI cases, 
antibiotic treatment, and IMI-related culling simulta-
neously. This option was not included in the investi-
gated strategies, as information about costs and effects 
of various hygiene measures are not readily available, 
as described above.
The choice of approach should also depend on the 
specific herd and situation, as different intervention 
strategies may be preferable depending on the main 
causative pathogen strain. The decision has to be taken 
by the farmer, who must decide which option fits best 
with their beliefs or ideas for the herd.
We did not consider nonantibiotic treatment for IMI 
in the current study. To investigate this possibility, the 
model would also have to include a distinction between 
mild, moderate, and severe clinical IMI cases, as non-
antibiotic treatments are mainly considered for mild or 
moderate clinical IMI (McDougall et al., 2009, 2016). 
This could be considered in future studies.
In addition, some of the strategies presented in the 
current paper involved strict culling rules to which 
farmers may not want to adhere. For that reason, we 
considered strategies in which groups of animals were 
excluded from culling, such as cows that were more than 
approximately 4 mo pregnant (notCullPregnant) or 
high-producing cows (notCullTop). The latter strategy 
in particular considers an earlier study on determinants 
for antimicrobial treatment, in which high-producing 
cows were more likely to be treated in some Danish 
herds (Gussmann et al., 2018a).
We also simulated other strategies, including a higher 
probability of heifers being treated; however, the results 
were quite similar to some of the other strategies, so 
they were not presented here. Nevertheless, Vaarst et 
al. (2006) found farmers are willing to adopt a culling 
strategy matching their goal for the herd, so includ-
ing some form of reactive culling in IMI intervention 
strategies is not unreasonable. However, this kind of 
culling affects the usual culling procedure, especially 
considering that we modeled a closed herd for which re-
placement heifers had to be available on-site. This may 
lead to problems when a larger number of animals are 
culled due to other, nonvoluntary reasons, such as other 
diseases. However, we concentrated on IMI interven-
tions and their economic and epidemiological effects, 
leaving further investigations into culling dynamics as 
a whole for future studies.
CONCLUSIONS
We showed that cow-specific intervention strategies 
for IMI (including reactive culling) can be economi-
cally beneficial in the long term, even more so than 
a strategy with increased antibiotic treatment. The 
increased income from milk, together with the reduced 
number of IMI cases, compensated for the extra inter-
vention costs, though economic benefits also depended 
on the transmission level in the herd. In addition, only 
1 strategy could not reduce the number of clinical cases 
compared with the default 3-d intramammary treat-
ment. The incidence was decreased either at the cost 
of an increased use of antibiotics or at the cost of the 
number of cows culled in relation to IMI. Therefore, the 
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farmer has to choose the right balance between treat-
ment and culling for a specific herd, taking into account 
their antimicrobial usage and longevity goals, as well 
as the main causative pathogen in the herd. We have 
shown that cow-specific treatment or culling decisions 
will, in most cases, reduce the incidence of clinical IMI 
while increasing income in the long term. The best op-
tion to achieve a stable and low number of IMI cases 
would be to reduce IMI transmission, but assessing the 
cost-effectiveness of this strategy is challenging due to 
a lack of data.
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